Clinical trial
A Single-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Batch Consistency of the EV71 Vaccine in Infants Aged 6 to 35 Months After Vaccination According to a Two-dose Immunization Schedule
NCT07026500 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Batch Consistency of the EV71 Vaccine in Infants Aged 6 to 35 Months After Vaccination According to a Two-dose Immunization Schedule
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 19, 2019
- Completion date
- May 31, 2020
- Enrollment
- 720 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ev71 vaccine